Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
opelkibart elmanitin (MGTA-117)
i
Other names:
MGTA-117, CD117-ADC
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(4)
News
Trials
Company:
Dianthus Therap
Drug class:
c-KIT-targeted antibody-drug conjugate, RNA polymerase 2 inhibitor
Related drugs:
‹
LOP628 (3)
NN3201 (2)
CD45-ADC (1)
HDP-101 (1)
HDP-103 (0)
LOP628 (3)
NN3201 (2)
CD45-ADC (1)
HDP-101 (1)
HDP-103 (0)
›
Associations
(4)
News
Trials
VERI cancer hierarchy
Reset Filters
KIT positive
Myelodysplastic Syndrome
KIT positive
Myelodysplastic Syndrome
MGTA-117
Sensitive: C3 – Early Trials
MGTA-117
Sensitive
:
C3
MGTA-117
Sensitive: C3 – Early Trials
MGTA-117
Sensitive
:
C3
KIT positive
Acute Myelogenous Leukemia
KIT positive
Acute Myelogenous Leukemia
MGTA-117
Sensitive: C3 – Early Trials
MGTA-117
Sensitive
:
C3
MGTA-117
Sensitive: C3 – Early Trials
MGTA-117
Sensitive
:
C3
KIT expression
Leukemia
KIT expression
Leukemia
MGTA-117
Sensitive: D – Preclinical
MGTA-117
Sensitive
:
D
MGTA-117
Sensitive: D – Preclinical
MGTA-117
Sensitive
:
D
KIT expression
Acute Myelogenous Leukemia
KIT expression
Acute Myelogenous Leukemia
MGTA-117
Sensitive: D – Preclinical
MGTA-117
Sensitive
:
D
MGTA-117
Sensitive: D – Preclinical
MGTA-117
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login